Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (31-40 of 365) with videos related to

Pageof 37
Sort By:
The Australian and New Zealand Journal of Psychiatry|June 2, 2023
Tau in dementia with Lewy bodiesKai Sin Chin, Leonid Churilov, Vincent Doré, et al.
Internal Medicine Journal|February 6, 2025
Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer's disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinicsJohannes C Michaelian, Christopher C Rowe, Susan E Kurrle, et al.
Scientific Reports|August 30, 2022
Mapping the association between tau-PET and Aβ-amyloid-PET using deep learningGihan P Ruwanpathirana, Robert C Williams, Colin L Masters, et al.
The International Journal of Biochemistry & Cell Biology|May 24, 2011
Amyloid-β: the seeds of darknessMichelle T Fodero-Tavoletti, Victor L Villemagne, Christopher C Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2017
Optimal Reference Region to Measure Longitudinal Amyloid-β Change with <sup>18</sup>F-Florbetaben PETSantiago Bullich, Victor L Villemagne, Ana M Catafau, et al.
Frontiers in Neurology|January 17, 2014
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associationsPaul A Yates, Victor L Villemagne, Kathryn A Ellis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal AnalysesGihan P Ruwanpathirana, Robert C Williams, Colin L Masters, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|November 13, 2015
Computer-aided detection of cerebral microbleeds in susceptibility-weighted imagingAmir Fazlollahi, Fabrice Meriaudeau, Luca Giancardo, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid PathologySiddharth Ramanan, Emma Flanagan, Cristian E Leyton, et al.
Molecular Neurobiology|August 12, 2008
The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementiasVictor L Villemagne, Michelle T Fodero-Tavoletti, Kerryn E Pike, et al.
Pageof 37

Showing results (31-40 of 365) with videos related to

Sort By:
Pageof 37
The Australian and New Zealand Journal of Psychiatry|June 2, 2023
Tau in dementia with Lewy bodiesKai Sin Chin, Leonid Churilov, Vincent Doré, et al.
Internal Medicine Journal|February 6, 2025
Is Australia ready for the rollout of amyloid-targeting therapies for Alzheimer's disease? Results from a national survey characterising current infrastructure capability, workforce and training needs of memory and cognition clinicsJohannes C Michaelian, Christopher C Rowe, Susan E Kurrle, et al.
Scientific Reports|August 30, 2022
Mapping the association between tau-PET and Aβ-amyloid-PET using deep learningGihan P Ruwanpathirana, Robert C Williams, Colin L Masters, et al.
The International Journal of Biochemistry & Cell Biology|May 24, 2011
Amyloid-β: the seeds of darknessMichelle T Fodero-Tavoletti, Victor L Villemagne, Christopher C Rowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2017
Optimal Reference Region to Measure Longitudinal Amyloid-β Change with <sup>18</sup>F-Florbetaben PETSantiago Bullich, Victor L Villemagne, Ana M Catafau, et al.
Frontiers in Neurology|January 17, 2014
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associationsPaul A Yates, Victor L Villemagne, Kathryn A Ellis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Impact of PET Reconstruction on Amyloid-β Quantitation in Cross-Sectional and Longitudinal AnalysesGihan P Ruwanpathirana, Robert C Williams, Colin L Masters, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|November 13, 2015
Computer-aided detection of cerebral microbleeds in susceptibility-weighted imagingAmir Fazlollahi, Fabrice Meriaudeau, Luca Giancardo, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid PathologySiddharth Ramanan, Emma Flanagan, Cristian E Leyton, et al.
Molecular Neurobiology|August 12, 2008
The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementiasVictor L Villemagne, Michelle T Fodero-Tavoletti, Kerryn E Pike, et al.
Pageof 37